Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management that have demonstrated significant weight loss effects
3.3.4 Pharmacodynamics After Multiple Doses of Oral Semaglutide In subjects with T2D, a statistically significant decrease in HbA 1c from a mean baseline level of 7.5% was seen after 10 weeks of treatment with 40 mg oral semaglutide versus placebo (treatment difference in change from baseline 1.5% [95% CI 1.8, 1.3]
some respond well to microdosing protocols that start lower and titrate gradually
And it was the DASH diet study, dietary approaches to stopping hypertension, and it was being published in the New England Journal of Medicine
Considering that this amino acid is essential for central nervous system (CNS) function and development (46), its decline has been associated with severe neurological disorders (47, 48)
SGLT2 deletion improves glucose homeostasis and preserves pancreatic -cell function
